<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Annals of Clinical and Experimental Neurology</journal-id><journal-title-group><journal-title xml:lang="en">Annals of Clinical and Experimental Neurology</journal-title><trans-title-group xml:lang="ru"><trans-title>Анналы клинической и экспериментальной неврологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2075-5473</issn><issn publication-format="electronic">2409-2533</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1496</article-id><article-id pub-id-type="doi">10.17816/ACEN.1496</article-id><article-id pub-id-type="edn">ROSKLX</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Original articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Оригинальные статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Multiparametric quantitative magnetic resonance neurography of the lumbosacral plexus in chronic demyelinating polyneuropathies</article-title><trans-title-group xml:lang="ru"><trans-title>Мультипараметрическая количественная МР-нейрография пояснично-крестцовых сплетений при хронических демиелинизирующих полинейропатиях</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0009-4851-9649</contrib-id><name-alternatives><name xml:lang="en"><surname>Tsaregorodtsev</surname><given-names>Dmitrii S.</given-names></name><name xml:lang="ru"><surname>Царегородцев</surname><given-names>Дмитрий Сергеевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Postgraduate Student, Radiologist, Radiology Department</p></bio><bio xml:lang="ru"><p>аспирант, врач-рентгенолог отдела лучевой диагностики</p></bio><email>tsaregorodtsev.dmitri@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9093-344X</contrib-id><name-alternatives><name xml:lang="en"><surname>Morozova</surname><given-names>Sofya N.</given-names></name><name xml:lang="ru"><surname>Морозова</surname><given-names>Софья Николаевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Med.), Researcher, Radiology Department</p></bio><bio xml:lang="ru"><p>канд. мед. наук, н. с. отд. лучевой диагностики</p></bio><email>tsaregorodtsev.dmitri@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7924-3405</contrib-id><name-alternatives><name xml:lang="en"><surname>Grishinа</surname><given-names>Darya A.</given-names></name><name xml:lang="ru"><surname>Гришина</surname><given-names>Дарья Александровна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Dr. Sci. (Med.), Head, Center for Peripheral Nervous System Diseases, Institute of Clinical and Preventive Neurology</p></bio><bio xml:lang="ru"><p>д-р мед. наук, рук. Центра заболеваний периферической нервной системы Института клинической и профилактической неврологии</p></bio><email>tsaregorodtsev.dmitri@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7023-7378</contrib-id><name-alternatives><name xml:lang="en"><surname>Murtazina</surname><given-names>Aysylu F.</given-names></name><name xml:lang="ru"><surname>Муртазина</surname><given-names>Айсылу Фанзировна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Med.), Researcher</p></bio><bio xml:lang="ru"><p>канд. мед. наук, н. с. научно-консультативного отдела</p></bio><email>tsaregorodtsev.dmitri@yandex.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0007-9862-0273</contrib-id><name-alternatives><name xml:lang="en"><surname>Subbotin</surname><given-names>Dmitrii M.</given-names></name><name xml:lang="ru"><surname>Субботин</surname><given-names>Дмитрий Михайлович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Clinical Geneticist, Researcher</p></bio><bio xml:lang="ru"><p>врач-генетик, н. с.</p></bio><email>tsaregorodtsev.dmitri@yandex.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4905-1303</contrib-id><name-alternatives><name xml:lang="en"><surname>Shchagina</surname><given-names>Olga A.</given-names></name><name xml:lang="ru"><surname>Щагина</surname><given-names>Ольга Анатольевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Dr. Sci. (Med.), Leading Researcher, DNA Diagnostics Laboratory, Head, Laboratory of Molecular Genetic Diagnostics</p></bio><bio xml:lang="ru"><p>д-р мед. наук, в. н. с. лаб. ДНК-диагностики, зав. лаб. молекулярно-генетической диагностики</p></bio><email>tsaregorodtsev.dmitri@yandex.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3820-4554</contrib-id><name-alternatives><name xml:lang="en"><surname>Krotenkova</surname><given-names>Marina V.</given-names></name><name xml:lang="ru"><surname>Кротенкова</surname><given-names>Марина Викторовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Dr. Sci. (Med.), Head, Radiology Department</p></bio><bio xml:lang="ru"><p>д-р мед. наук, рук. отд. лучевой диагностики</p></bio><email>tsaregorodtsev.dmitri@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3956-6362</contrib-id><name-alternatives><name xml:lang="en"><surname>Suponeva</surname><given-names>Natalia A.</given-names></name><name xml:lang="ru"><surname>Супонева</surname><given-names>Наталья Александровна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Dr. Sci. (Med.), Corr. Member of RAS, Director, Institute of Neurorehabilitation and Recovery Technologies</p></bio><bio xml:lang="ru"><p>д-р мед. наук, член-корр. РАН, директор Института нейрореабилитации и восстановительных технологий</p></bio><email>tsaregorodtsev.dmitri@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Russian Center of Neurology and Neurosciences</institution></aff><aff><institution xml:lang="ru">Российский центр неврологии и нейронаук</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">N.P. Bochkov Research Centre of Medical Genetics</institution></aff><aff><institution xml:lang="ru">Медико-генетический научный центр имени академика Н.П. Бочкова</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2026-09-30" publication-format="electronic"><day>30</day><month>09</month><year>2026</year></pub-date><volume>20</volume><issue>3</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>38</fpage><lpage>49</lpage><history><date date-type="received" iso-8601-date="2026-03-03"><day>03</day><month>03</month><year>2026</year></date><date date-type="accepted" iso-8601-date="2026-03-24"><day>24</day><month>03</month><year>2026</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2026, Tsaregorodtsev D.S., Morozova S.N., Grishinа D.A., Murtazina A.F., Subbotin D.M., Shchagina O.A., Krotenkova M.V., Suponeva N.A.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2026, Царегородцев Д.С., Морозова С.Н., Гришина Д.А., Муртазина А.Ф., Субботин Д.М., Щагина О.А., Кротенкова М.В., Супонева Н.А.</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="en">Tsaregorodtsev D.S., Morozova S.N., Grishinа D.A., Murtazina A.F., Subbotin D.M., Shchagina O.A., Krotenkova M.V., Suponeva N.A.</copyright-holder><copyright-holder xml:lang="ru">Царегородцев Д.С., Морозова С.Н., Гришина Д.А., Муртазина А.Ф., Субботин Д.М., Щагина О.А., Кротенкова М.В., Супонева Н.А.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://annaly-nevrologii.com/pathID/article/view/1496">https://annaly-nevrologii.com/pathID/article/view/1496</self-uri><abstract xml:lang="en"><p><bold>Introduction</bold><bold>. </bold>Chronic demyelinating polyneuropathies, including chronic inflammatory demyelinating polyneuropathy (CIDP) and hereditary motor and sensory neuropathy type 1 (HMSN1), are characterized by clinical heterogeneity and diagnostic challenges. Electrophysiological methods do not always reliably distinguish between hereditary and acquired forms, highlighting the need for additional objective biomarkers.</p> <p>The study<bold> aim</bold> was to evaluate the diagnostic potential of multiparametric quantitative MR neurography of the lumbosacral plexus in patients with chronic demyelinating polyneuropathies of different etiologies.</p> <p><bold>Materials and methods</bold><bold>.</bold> Data were acquired from 30 patients with genetically confirmed HMSN1, 31 patients with CIDP (fulfilling EAN/PNS 2021 electrodiagnostic criteria), and 27 healthy volunteers. Imaging was performed on a 3T MRI scanner using quantitative MR techniques: diffusion tensor imaging (fractional anisotropy — FA; mean, axial, and radial diffusivity — MD, AD, RD), T2 relaxometry (apparent T2 relaxation time — T2app; proton density — PD), and magnetization transfer imaging (MTR). Quantitative parameters were analyzed at the level of the L5–S2 nerve roots bilaterally.</p> <p><bold>Results.</bold> Both patient groups showed significantly reduced FA and increased MD and RD compared to controls, reflecting a demyelinating pattern of injury. AD did not differ significantly. Patients with HMSN1 showed more pronounced changes in PD and MTR compared to the CIDP group.</p> <p><bold>Conclusion</bold><bold>.</bold> Multiparametric quantitative MR neurography is associated with differences in microstructural changes between patient groups with chronic demyelinating polyneuropathies and may serve as a promising tool for differentiating hereditary from acquired forms.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Введение</bold><bold>. </bold>Хронические демиелинизирующие полинейропатии, включая хроническую воспалительную демиелинизирующую полинейропатию (ХВДП) и наследственную моторно-сенсорную нейропатию 1-го типа (НМСН1), характеризуются клинической гетерогенностью и трудностями в дифференциальной диагностике. Электрофизиологические методы диагностики не всегда позволяют однозначно разграничить наследственные и приобретённые формы, что определяет необходимость поиска дополнительных объективных биомаркеров.</p> <p><bold>Цель</bold><bold> </bold>исследования — оценить диагностические возможности мультипараметрической количественной МР-нейрографии пояснично-крестцовых сплетений у пациентов с хроническими демиелинизирующими полинейропатиями различной этиологии.</p> <p><bold>Материалы и методы</bold><bold>.</bold> В исследование включены 30 пациентов с генетически подтверждённой НМСН1, 31 пациент с ХВДП (полное соответствие электродиагностическим критериям EAN/PNS 2021) и 27 здоровых добровольцев. Обследование выполнено на 3 Тл МР-томографе с применением количественных МР-методик: диффузионно-тензорной МРТ (фракционная анизотропия — ФА; средняя, аксиальная и радиальная диффузия — СД, АД, РД), Т2-релаксометрии (измеряемое время Т2-релаксации — T2app, протонная плотность — PD) и визуализации с переносом намагниченности (MTR). Количественные параметры анализировали на уровне передних ветвей L5–S2 с обеих сторон.</p> <p><bold>Результаты</bold><bold>.</bold> В обеих группах пациентов выявлено достоверное снижение ФА и повышение СД и РД по сравнению с контролем, что отражает демиелинизирующий характер поражения. АД статистически значимо не различалась. У пациентов с НМСН1 отмечены более выраженные изменения PD и MTR по сравнению с группой ХВДП.</p> <p><bold>Заключение</bold><bold>.</bold> Мультипараметрическая количественная МР-нейрография ассоциирована с различиями в микроструктурных изменениях между группами пациентов с хроническими демиелинизирующими полинейропатиями и может рассматриваться как перспективный инструмент в дифференциальной диагностике наследственных и приобретённых форм заболевания.</p></trans-abstract><kwd-group xml:lang="en"><kwd>chronic inflammatory demyelinating polyneuropathy</kwd><kwd>hereditary motor-sensory neuropathy type 1</kwd><kwd>Charcot–Marie–Tooth disease type 1</kwd><kwd>quantitative MR neurography</kwd><kwd>diffusion tensor imaging</kwd><kwd>T2 relaxometry</kwd><kwd>magnetization transfer imaging</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>хроническая воспалительная демиелинизирующая полинейропатия</kwd><kwd>наследственная моторно-сенсорная нейропатия 1-го типа</kwd><kwd>болезнь Шарко–Мари–Тута 1-го типа</kwd><kwd>количественная МР-нейрография</kwd><kwd>диффузионно-тензорная магнитно-резонансная томография</kwd><kwd>Т2-релаксометрия</kwd><kwd>визуализация с переносом намагниченности</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Hanewinckel R, van Oijen M, Ikram MA, van Doorn PA. The epidemiology and risk factors of chronic polyneuropathy. Eur J Epidemiol. 2016;31(1):5–20. doi: 10.1007/s10654-015-0094-6</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Callaghan BC, Price RS, Feldman EL. Distal symmetric polyneuropathy: a review. JAMA. 2015;314(20):2172–2181. doi: 10.1001/jama.2015.13611</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Li Y, Yi JS, Guptill JT, et al. Immune dysregulation in chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol. 2024;391:578360. doi: 10.1016/j.jneuroim.2024.578360</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Berger P, Young P, Suter U. Molecular cell biology of Charcot-Marie-Tooth disease. Neurogenetics. 2002;4(1):1–15. doi: 10.1007/s10048-002-0130-z</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Su Y, Brooks DG, Li L, et al. Myelin protein zero gene mutated in Charcot-Marie-tooth type 1B patients. Proc Natl Acad Sci USA. 1993;90(22):10856–10860. doi: 10.1073/pnas.90.22.10856</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Chaudhary UJ, Rajabally YA. Underdiagnosis and diagnostic delay in chronic inflammatory demyelinating polyneuropathy. J Neurol. 2021;268(4):1366–1373. doi: 10.1007/s00415-020-10287-7</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Гришина Д.А., Супонева Н.А., Арестова А.С. и др. Гипердиагностика хронической воспалительной демиелинизирующей полирадикулонейропатии в России. Анналы клинической и экспериментальной неврологии. 2023;17(3):5–13. Grishina DA, Suponeva NA, Arestova AS, et al. Chronic inflammatory demyelinating polyradiculoneuropathy overdiagnosis in Russia. Annals of Clinical and Experimental Neurology. 2023;17(3):5–13. doi: 10.54101/ACEN.2023.3.1</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Пирадов М.А., Супонева Н.А., Гришина Д.А. Полинейропатии: алгоритмы диагностики и лечения. М.; 2022. Piradov MA, Suponeva NA, Grishina DA. Polineuropathies: diagnostic and treatment algorithms. Moscow; 2022. (In Russ.)</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Van den Bergh PYK, van Doorn PA, Hadden RDM, et al. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision. J Peripher Nerv Syst. 2021;26(3):242–268. doi: 10.1111/jns.12455</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Preisner F, Pitarokoili K, Lueling B, et al. Quantitative magnetic resonance neurography in chronic inflammatory demyelinating polyradiculoneuropathy: a longitudinal study over 6 years. Ann Clin Transl Neurol. 2024;11(3):593–606. doi: 10.1002/acn3.51978</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Zaidman CM, Pestronk A. Nerve size in chronic inflammatory demyelinating neuropathy varies with disease activity and therapy response over time: a retrospective ultrasound study. Muscle Nerve. 2014;50(5):733–738. doi: 10.1002/mus.24227</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Nasr-Eldin YK, Cartwright MS, Hamed A, et al. Neuromuscular ultrasound in polyneuropathies. J Ultrasound Med. 2024;43(7):1181–1198. doi: 10.1002/jum.16447</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Сафина Д.Р., Девликамова Ф.И. Возможности и ограничения ультразвукового исследования нервов при полинейропатиях. Практическая медицина. 2024; 22(3):29–36. Safina DR, Devlikamova FI. Possibilities and limitations of nerve ultrasound in polyneuropathies. Practical medicine. 2024;22(3):29–36. doi: 10.32000/2072-1757-2024-3-29-36</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Kramer M, Grimm A, Winter N, et al. Nerve ultrasound as helpful tool in polyneuropathies. Diagnostics (Basel). 2021;11(2):211. doi: 10.3390/diagnostics11020211</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Foesleitner O, Kirchner M, Preisner F, et al. High-resolution US vs MR neurography for diagnosis of upper extremity peripheral nerve disorders. Radiology. 2025;314(3):e232063. doi: 10.1148/radiol.232063</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Kollmer J, Bendszus M. Magnetic resonance neurography: improved diagnosis of peripheral neuropathies. Neurotherapeutics. 2021;18(4):2368–2383. doi: 10.1007/s13311-021-01166-8</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Vaeggemose M, Haakma W, Pham M, et al. Diffusion tensor imaging MR Neurography detects polyneuropathy in type 2 diabetes. J Diabetes Complications. 2020;34(2):107439. doi: 10.1016/j.jdiacomp.2019.107439</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Jeon T, Fung MM, Koch KM, et al. Peripheral nerve diffusion tensor imaging: overview, pitfalls, and future directions. J Magn Reson Imaging. 2018;47(5):1171–1189. doi: 10.1002/jmri.25876</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Yoon D, Lutz AM. Diffusion tensor imaging of peripheral nerves: current status and new developments. Semin Musculoskelet Radiol. 2023;27(6):641–648. doi: 10.1055/s-0043-1775742</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Bäumer P, Pham M, Ruetters M, et al. Peripheral neuropathy: detection with diffusion-tensor imaging. Radiology. 2014;273(1):185–193. doi: 10.1148/radiol.14132837</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Song SK, Sun SW, Ju WK, et al. Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia. Neuroimage. 2003;20(3):1714–1722. doi: 10.1016/j.neuroimage.2003.07.005</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Heiland S, Sartor K, Martin E, et al. In vivo monitoring of age-related changes in rat brain using quantitative diffusion magnetic resonance imaging and magnetic resonance relaxometry. Neurosci Lett. 2002;334(3):157–160. doi: 10.1016/s0304-3940(02)01073-x</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Wolff SD, Balaban RS. Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo. Magn Reson Med. 1989;10(1):135–144. doi: 10.1002/mrm.1910100113</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Yiannakas MC, Schneider T, Yoneyama M, et al. Magnetisation transfer ratio combined with magnetic resonance neurography is feasible in the proximal lumbar plexus using healthy volunteers at 3T. Sci Rep. 2020;10(1):14568. doi: 10.1038/s41598-020-71570-1</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Vaeggemose M, Vaeth S, Pham M, et al. Magnetic resonance neurography and diffusion tensor imaging of the peripheral nerves in patients with Charcot-Marie-Tooth Type 1A. Muscle Nerve. 2017;56(6):E78–E84. doi: 10.1002/mus.25691</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Морозова С.Н., Гришина Д.А., Орлов В.А. и др. Количественные МРТ-методики оценки периферических нервов. Нервно-мышечные болезни. 2024;14(1):76–85. Morozova SN, Grishina DA, Orlov VA, et al. Quantitative MRI assessment of peripheral nerves. Neuromuscular Diseases. 2024;14(1):76–85. doi: 10.17650/2222-8721-2024-14-1-76-85</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Yeh FC. DSI Studio: an integrated tractography platform and fiber data hub for accelerating brain research. Nat Methods. 2025;22(8):1617–1619. doi: 10.1038/s41592-025-02762-8</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Heckel A, Weiler M, Xia A, et al. Peripheral nerve diffusion tensor imaging: assessment of axon and myelin sheath integrity. PLoS One. 2015;10(6):e0130833. doi: 10.1371/journal.pone.0130833</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Chen H, Huang X, Bao Y, et al. The diagnostic value of quantitative assessment of MR neurography in chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis. Br J Radiol. 2023;96(1151):20221037. doi: 10.1259/bjr.20221037</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Zhu Y, Sun X, Fan D, Liu X. Nerve diameter and DTI parameters maybe potential markers for clinical trial in patients with Charcot-Marie-tooth disease type 1A. Eur J Neurol. 2025;32(6):e70220. doi: 10.1111/ene.70220</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Fortanier E, Ogier AC, Delmont E, et al. Quantitative assessment of sciatic nerve changes in Charcot-Marie-Tooth type 1A patients using magnetic resonance neurography. Eur J Neurol. 2020;27(8):1382–1389. doi: 10.1111/ene.14303</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Lüling B, Preisner F, Motte J, et al. Comparison of imaging markers of nerve ultrasound and MR-neurography in a longitudinal course in chronic inflammatory demyelinating polyneuropathy. Ther Adv Neurol Disord. 2025;18:17562864251342336. doi: 10.1177/17562864251342336</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Weiskopf N, Suckling J, Williams G, et al. Quantitative multi-parameter mapping of R1, PD(*), MT, and R2(*) at 3T: a multi-center validation. Front Neurosci. 2013;7:95. doi: 10.3389/fnins.2013.00095</mixed-citation></ref></ref-list></back></article>
